Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 4
1983 6
1984 10
1985 23
1986 17
1987 45
1988 38
1989 42
1990 61
1991 110
1992 81
1993 101
1994 75
1995 90
1996 74
1997 74
1998 60
1999 74
2000 68
2001 59
2002 65
2003 51
2004 53
2005 45
2006 33
2007 37
2008 31
2009 25
2010 25
2011 24
2012 22
2013 21
2014 21
2015 26
2016 35
2017 34
2018 25
2019 27
2020 27
2021 23
2022 15
2023 9
2024 17
2025 15
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,755 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
CONSENSUS Trial Study Group. CONSENSUS Trial Study Group. N Engl J Med. 1987 Jun 4;316(23):1429-35. doi: 10.1056/NEJM198706043162301. N Engl J Med. 1987. PMID: 2883575 Clinical Trial.
To evaluate the influence of the angiotensin-converting-enzyme inhibitor enalapril (2.5 to 40 mg per day) on the prognosis of severe congestive heart failure (New York Heart Association [NYHA] functional class IV), we randomly assigned 253 patients in a double-blind study …
To evaluate the influence of the angiotensin-converting-enzyme inhibitor enalapril (2.5 to 40 mg per day) on the prognosis of severe …
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
SOLVD Investigators; Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. SOLVD Investigators, et al. N Engl J Med. 1991 Aug 1;325(5):293-302. doi: 10.1056/NEJM199108013250501. N Engl J Med. 1991. PMID: 2057034 Free article. Clinical Trial.
We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. ...CONCLUSIONS: The addition of enalapril to conventional thera …
We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chr …
Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
He YM, Feng L, Huo DM, Yang ZH, Liao YH. He YM, et al. Nephrology (Carlton). 2013 Sep;18(9):605-14. doi: 10.1111/nep.12134. Nephrology (Carlton). 2013. PMID: 23869492
AIM: Both enalapril and losartan are effective and widely used in patients with chronic kidney disease (CKD). This review aimed to evaluate the benefits of enalapril and losartan in adults with CKD. METHODS: PubMed, EMBASE, the Cochrane Library and ClinicalTrials.go …
AIM: Both enalapril and losartan are effective and widely used in patients with chronic kidney disease (CKD). This review aimed to ev …
Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
Rizzoni D. Rizzoni D. Curr Med Res Opin. 2016 Oct;32(sup2):13-15. doi: 10.1080/03007995.2016.1218835. Curr Med Res Opin. 2016. PMID: 27779457
OBJECTIVE: This meta-analysis evaluates the efficacy and safety of lercanidipine/enalapril fixed-dose combination in patients with mild to moderate essential hypertension. ...CONCLUSION: This meta-analysis supports the use of the lercanidipine/enalapril fixed-dose c …
OBJECTIVE: This meta-analysis evaluates the efficacy and safety of lercanidipine/enalapril fixed-dose combination in patients with mi …
Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults.
Van Hecken A, Burckhardt BB, Khalil F, de Hoon J, Klingmann I, Herbots M, Laeer S, Lagler FB, Breitkreutz J. Van Hecken A, et al. Clin Pharmacol Drug Dev. 2020 Feb;9(2):203-213. doi: 10.1002/cpdd.728. Epub 2019 Aug 14. Clin Pharmacol Drug Dev. 2020. PMID: 31411383 Clinical Trial.
The angiotensin-converting enzyme inhibitor enalapril is commonly used to treat chronic heart failure in children. Because some children are unable to swallow capsules or tablets, a new, age-appropriate, orodispersible minitablet (ODMT) containing 1 mg of enalapril …
The angiotensin-converting enzyme inhibitor enalapril is commonly used to treat chronic heart failure in children. Because some child …
[Enalapril-clinical experience in Bulgaria].
Taseva T. Taseva T. Vutr Boles. 2000;32(2):27-9. Vutr Boles. 2000. PMID: 11227662 Bulgarian.
The authors present the results of clinical trail about treatment of arterial hypertension with ENAP (Enalapril) fo KRKA in centers of Bulgaria. Enalapril is ACE-inhibitor usually administered orally once daily, decreases blood pressure by lowering peripheral vascul …
The authors present the results of clinical trail about treatment of arterial hypertension with ENAP (Enalapril) fo KRKA in centers o …
Enalapril for congestive heart failure.
Kjekshus J, Swedberg K. Kjekshus J, et al. Am J Cardiol. 1989 Feb 21;63(8):26D-32D. doi: 10.1016/0002-9149(89)90414-1. Am J Cardiol. 1989. PMID: 2537563 Clinical Trial.
The overall withdrawal rate was low, and was comparable in the 2 treatment groups (16%; enalapril, n = 22, placebo, n = 18). Symptomatic hypotension was observed in 17% (n = 21) of the enalapril group vs 0% of the placebo group. Hypotension was the reason for withdr …
The overall withdrawal rate was low, and was comparable in the 2 treatment groups (16%; enalapril, n = 22, placebo, n = 18). Symptoma …
Efficacy and Safety of Enalapril and Propranolol on Neurologic Recovery After Isolated Severe Traumatic Brain Injury: A Randomized Clinical Trial.
Mahmoodkhani M, Sahraei A, Shafiei M, Bowers C, Sourani A, Foroughi M, Mahdavi SB, Sharafi M, Tehrani DS, Khah RN, Veisi S. Mahmoodkhani M, et al. World Neurosurg. 2025 Jul;199:124078. doi: 10.1016/j.wneu.2025.124078. Epub 2025 May 20. World Neurosurg. 2025. PMID: 40404011 Free article. Clinical Trial.
Although propranolol and enalapril have been proposed to have beneficial effects as cardiovascular stabilizers in TBI, many neurologic effects remain obscure. ...All the patients age >18 years with severe isolated TBI who had legal consent to participate (by guardians) …
Although propranolol and enalapril have been proposed to have beneficial effects as cardiovascular stabilizers in TBI, many neurologi …
Enalapril in low-renin essential hypertension.
Wilkins LH, Dustan HP, Walker JF, Oparil S. Wilkins LH, et al. Clin Pharmacol Ther. 1983 Sep;34(3):297-302. doi: 10.1038/clpt.1983.171. Clin Pharmacol Ther. 1983. PMID: 6309461 Clinical Trial.
Neither supine nor standing systolic pressure nor standing diastolic pressure decreased significantly from pretreatment levels during enalapril once or twice daily. Heart rates measured after 5 min supine rest were not altered by enalapril. ...No adverse effect attr …
Neither supine nor standing systolic pressure nor standing diastolic pressure decreased significantly from pretreatment levels during ena …
Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study.
Derosa G, Bonaventura A, Romano D, Bianchi L, Fogari E, D'Angelo A, Maffioli P. Derosa G, et al. J Am Soc Hypertens. 2014 Jun;8(6):422-8. doi: 10.1016/j.jash.2014.03.329. Epub 2014 Apr 4. J Am Soc Hypertens. 2014. Retraction in: J Am Soc Hypertens. 2015 Oct;9(10):822. doi: 10.1016/j.jash.2015.08.013. PMID: 24836352 Retracted. Clinical Trial.
A total of 359 patients were randomized to enalapril 20 mg, lercanidipine 10 mg, or enalapril/lercanidipine 20/10 mg fixed combination. ...All treatments increased sRAGE levels, and decreased sCD40 L and MPO, even if enalapril/lercanidipine combination was mo …
A total of 359 patients were randomized to enalapril 20 mg, lercanidipine 10 mg, or enalapril/lercanidipine 20/10 mg fixed com …
1,755 results